TrialEuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology2022

Evolocumab for prevention of microvascular dysfunction in patients undergoing percutaneous coronary intervention: the randomised, open-label EVOCATION trial.

Masaharu Ishihara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.